Clinical Trial: Washington University WU 409: Immune Responses to Rabies Vaccine.

U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399951) titled 'Washington University WU 409: Immune Responses to Rabies Vaccine.' on Jan. 27.

Brief Summary: This study will evaluate the immune response to rabies vaccination persons 18 years and older. We will evaluate thirty healthy participants across three cohorts: 1) standard rabies pre-exposure prophylaxis regimen (two doses of Imovax(R) or RabAvert(R) seven days apart with no RIG); 2) rabies pre-exposure prophylaxis regimen + day 0 RIG (two doses of Imovax(R) or RabAvert(R) seven days apart, with RIG administered at day 0); 3) rabies pre-exposure prophylaxis regimen + day 28 RIG (two doses of Imovax(R) or RabAvert(R) seven days apart, with...